Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

September 30, 2017

Primary Completion Date

May 1, 2019

Study Completion Date

May 1, 2020

Conditions

Heart FailureLeft Ventricular Assist DeviceNatriuretic Peptide

Interventions

DRUG

CD-NP

Participants will receive a subcutaneous injection of CD-NP (5 mcg / kg) daily for 3 days

OTHER

Placebo

Participants will receive an \~ 1mL subcutaneous injection of normal saline, in lieu of Study Drug, for 3 days